Contact system activation in severe infectious diseases

Journal of Molecular Medicine

Volumn 88, Issue 2, 2010, Pages 121-126

  Oehmcke, Sonja ^a   Herwald, Heiko ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Coagulation; Contact system; Sepsis; Streptococcus pyogenes

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; CLINDAMYCIN; COMPLEMENT COMPONENT C1S INHIBITOR; DELTIBANT; DROTRECOGIN; HIGH MOLECULAR WEIGHT KININOGEN; PLACEBO; PLASMA KALLIKREIN; THROMBOPLASTIN;

ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; BLEEDING; CLINICAL TRIAL; CYTOKINE PRODUCTION; DISSEMINATED INTRAVASCULAR CLOTTING; GRAM NEGATIVE INFECTION; GROUP A STREPTOCOCCAL INFECTION; HEMOSTASIS; HOST PATHOGEN INTERACTION; HUMAN; HYPOTENSION; INFLAMMATION; INNATE IMMUNITY; KALLIKREIN KININ SYSTEM; MENINGOCOCCEMIA; NONHUMAN; REVIEW; SEPSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOGENESIS; TOXIC SHOCK SYNDROME;

BACTERIAL INFECTIONS; BACTERIAL PROTEINS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BRADYKININ; HEMOSTASIS; HUMANS; SEPSIS;

EID: 77951205291     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-009-0564-y     Document Type: Review

References (63)

1. GS Martin DM Mannino S Eaton M Moss 2003 The epidemiology of sepsis in the United States from 1979 through 2000 N Engl J Med 348 1546 1554 10.1056/NEJMoa022139 12700374 (Pubitemid 36437931)
2. NC Riedemann RF Guo PA Ward 2003 Novel strategies for the treatment of sepsis Nat Med 9 517 524 10.1038/nm0503-517 10.1038/nm0503-517 1:CAS:528:DC%2BD3sXjtlamt7Y%3D 12724763 nm0503-517 [pii] (Pubitemid 36597096)
3. RA Pixley S Zellis P Bankes RA DeLa Cadena JD Page CF Scott J Kappelmayer EG Wyshock JJ Kelly RW Colman 1995 Prognostic value of assessing contact system activation and factor V in systemic inflammatory response syndrome Crit Care Med 23 41 51 10.1097/00003246-199501000-00010 1:STN:280:DyaK2M%2FpsVGguw%3D%3D 7528118
4. AA Hasan DB Cines H Herwald AH Schmaier W Müller-Esterl 1995 Mapping the cell binding site on high molecular weight kininogen domain 5 J BiolChem 270 19256 19261 1:CAS:528:DyaK2MXnsFyhu74%3D
5. H Herwald M Mörgelin HG Svensson U Sjöbring 2001 Zinc-dependent conformational changes in domain D5 of high molecular mass kininogen modulate contact activation Eur J Biochem 268 396 404 10.1046/j.1432-1033.2001.01888.x 1:CAS:528:DC%2BD3MXptVCitQ%3D%3D 11168375
6. AB Ben Nasr H Herwald W Müller-Esterl L Björck 1995 Human kininogens interact with M protein, a bacterial surface protein and virulence determinant Biochem J 305 173 180 1:CAS:528:DyaK2MXjtFeltLc%3D 7826326
7. E Mattsson H Herwald H Cramer K Persson U Sjöbring L Björck 2001 Staphylococcus aureus induces release of bradykinin in human plasma Infect Immun 69 3877 3882 10.1128/IAI.69.6.3877-3882.2001 1:CAS:528: DC%2BD3MXjvFyru7o%3D 11349054 (Pubitemid 32493308)
8. H Herwald J Dedio R Kellner M Loos W Müller-Esterl 1996 Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor J Biol Chem 271 13040 13047 10.1074/jbc.271.22.13040 1:CAS:528:DyaK28XjtlGisro%3D 8662673 (Pubitemid 26176705)
9. F Mahdi Z Shariat-Madar A Kuo M Carinato DB Cines AH Schmaier 2004 Mapping the interaction between high molecular mass kininogen and the urokinase plasminogen activator receptor J Biol Chem 279 16621 16628 10.1074/jbc. M313850200 M313850200 10.1074/jbc.M313850200 1:CAS:528:DC%2BD2cXivF2qurw%3D 14764580 [pii] (Pubitemid 38509363)
10. Y Nakazawa K Joseph AP Kaplan 2002 Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5 International immunopharmacology 2 1875 1885 S1567-5769(02)00182-0 [pii] 10.1016/S1567-5769(02)00182-0 1:CAS:528:DC%2BD38XovFGhtbg%3D 12494915 (Pubitemid 35373929)
11. R Perkins MD Ngo F Mahdi Z Shariat-Madar 2008 Identification of lipopolysaccharide binding site on high molecular weight kininogen Biochem Biophys Res Commun 366 938 943 S0006-291X(07)02654-X [pii] 10.1016/j.bbrc.2007. 12.042 1:CAS:528:DC%2BD1cXislyksA%3D%3D 18083112 10.1016/j.bbrc.2007.12.042
12. EA Nordahl V Rydengård M Mörgelin A Schmidtchen 2005 Domain 5 of high molecular weight kininogen is antibacterial J Biol Chem 280 34832 34839 10.1074/jbc.M507249200 1:CAS:528:DC%2BD2MXhtVyks77N 16091369 (Pubitemid 41504617)
13. RW Colman BA Jameson Y Lin D Johnson SA Mousa 2000 Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis Blood 95 543 550 1:CAS:528:DC%2BD3cXlsFGitA%3D%3D 10627460
14. RW Colman AH Schmaier 1997 Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes Blood 90 3819 3843 1:CAS:528:DyaK2sXnt12rtL4%3D 9354649
15. SP Kunapuli RA DeLa Cadena RW Colman 1993 Deletion mutagenesis of high molecular weight kininogen light chain. Identification of two anionic surface binding subdomains J Biol Chem 268 2486 2492 1:CAS:528:DyaK3sXkt1Ghtbo%3D 8428925
16. C Kannemeier A Shibamiya F Nakazawa H Trusheim C Ruppert P Markart Y Song E Tzima E Kennerknecht M Niepmann ML von Bruehl D Sedding S Massberg A Günther B Engelmann KT Preissner 2007 Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation Proc Natl Acad Sci U S A 104 6388 6393 0608647104 [pii] 10.1073/pnas.0608647104 1:CAS:528: DC%2BD2sXks1Sgsrw%3D 17405864 10.1073/pnas.0608647104 (Pubitemid 47186104)
17. S Oehmcke M Mörgelin H Herwald 2009 Activation of the human contact system on neutrophil extracellular traps J Innate Immun 1 225 231 10.1159/000203700
18. AE Davis 3rd 2008 Hereditary angioedema: A current state-of-the-art review, III: mechanisms of hereditary angioedema Ann Allergy Asthma Immunol 100 S7 12 10.1016/S1081-1206(10)60580-7 1:CAS:528:DC%2BD1cXhslSnsLo%3D 18220146
19. IM Frick L Björck H Herwald 2007 The dual role of the contact system in bacterial infectious disease Thromb Haemost 98 497 502 1:CAS:528: DC%2BD2sXhtFKjtrvJ 17849037
20. JA Russell 2006 Management of sepsis N Engl J Med 355 1699 1713 10.1056/NEJMra043632 1:CAS:528:DC%2BD28XhtFWgu7vF 17050894 (Pubitemid 44583960)
21. D Rittirsch MA Flierl PA Ward 2008 Harmful molecular mechanisms in sepsis Nat Rev Immunol 8 776 787 nri2402 [pii] 10.1038/nri2402 1:CAS:528: DC%2BD1cXhtFKkur%2FM 18802444 10.1038/nri2402
22. F Fourrier M Jourdain A Tournois C Caron J Goudemand C Chopin 1995 Coagulation inhibitor substitution during sepsis Intensive Care Med 21 Suppl 2 S264 268 10.1007/BF01740765 8636534
23. B Risberg S Andreasson E Eriksson 1991 Disseminated intravascular coagulation Acta Anaesthesiol Scand Suppl 95 60 71 10.1111/j.1399-6576.1991. tb03401.x 1:STN:280:DyaK38%2FisVyhsA%3D%3D 1927229
24. M Levi H Ten Cate 1999 Disseminated intravascular coagulation N Engl J Med 341 586 592 10.1056/NEJM199908193410807 1:CAS:528:DyaK1MXlvVOnsbc%3D 10451465 (Pubitemid 29384168)
25. JW Mason U Kleeberg P Dolan RW Colman 1970 Plasma kallikrein and Hageman factor in Gram-negative bacteremia Ann Intern Med 73 545 551 1:CAS:528:DyaE3MXitVam 5506006
26. Pixley RA, Colman RW (1997) The kallikrein-kinin system in sepsis syndrome. Handbook of Immunopharmacology-The Kinin System Farmer SG, ed. New York: Academic Press: 173-186
27. OD Saugstad L Buo HT Johansen O Roise AO Aasen 1992 Activation of the plasma kallikrein-kinin system in respiratory distress syndrome Pediatr Res 32 431 435 10.1203/00006450-199210000-00012 1:CAS:528:DyaK3sXitVCitA%3D%3D 1437396
28. AO Aasen N Smith-Erichsen E Amundsen 1983 Plasma kallikrein-kinin system in septicemia Arch Surg 118 343 346 1:STN:280:DyaL3s7is1Sjtg%3D%3D 6549898
29. T Renne M Pozgajova S Gruner K Schuh HU Pauer P Burfeind D Gailani B Nieswandt 2005 Defective thrombus formation in mice lacking coagulation factor XII J Exp Med 202 271 281 jem.20050664 [pii] 10.1084/jem.20050664 1:CAS:528:DC%2BD2MXmsVKht7k%3D 16009717 10.1084/jem.20050664 (Pubitemid 41043823)
30. D Gailani T Renne 2007 Intrinsic pathway of coagulation and arterial thrombosis Arterioscler Thromb Vasc Biol 27 2507 2513 ATVBAHA.107.155952 [pii] 10.1161/ATVBAHA.107.155952 1:CAS:528:DC%2BD2sXhtlahtLrF 17916770 10.1161/ATVBAHA.107.155952 (Pubitemid 350158899)
31. N Kaufman JD Page RA Pixley R Schein AH Schmaier RW Colman 1991 Alpha 2-macroglobulin-kallikrein complexes detect contact system activation in hereditary angioedema and human sepsis Blood 77 2660 2667 1:STN:280: DyaK3M3lsFKrtA%3D%3D 1710516
32. M van Deuren P Brandtzaeg JW van der Meer 2000 Update on meningococcal disease with emphasis on pathogenesis and clinical management Clin Microbiol Rev 13 144 166 10.1128/CMR.13.1.144-166.2000 10627495
33. WA Wuillemin K Fijnvandraat BH Derkx M Peters W Vreede H ten Cate CE Hack 1995 Activation of the intrinsic pathway of coagulation in children with meningococcal septic shock Thromb Haemost 74 1436 1441 1:CAS:528: DyaK28XjtlyhsA%3D%3D 8772216
34. S Sriskandan J Cohen 2000 Kallikrein-kinin system activation in streptococcal toxic shock syndrome Clin Infect Dis 30 961 962 10.1086/313827 1:CAS:528:DC%2BD3cXlvVyrsLs%3D 10880316 (Pubitemid 32250347)
35. RA Pixley R De La Cadena JD Page N Kaufman EG Wyshock A Chang FBJ Taylor RW Colman 1993 The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons J Clin Invest 91 61 68 10.1172/JCI116201 1:CAS:528:DyaK3sXpvFehug%3D%3D 7678610
36. RA Pixley RA DeLa Cadena JD Page N Kaufman EG Wyshock RW Colman A Chang FB Taylor Jr 1992 Activation of the contact system in lethal hypotensive bacteremia in a baboon model Am J Pathol 140 897 906 1:STN:280: DyaK383it1Smsw%3D%3D 1373271
37. DJ Campbell 2001 The kallikrein-kinin system in humans Clin Exp Pharmacol Physiol 28 1060 1065 10.1046/j.1440-1681.2001.03564.x 1:CAS:528:DC%2BD38XptVWh 11903316 (Pubitemid 34053524)
38. C Cayla M Todiras R Iliescu VV Saul V Gross B Pilz G Chai VF Merino JB Pesquero OC Baltatu M Bader 2007 Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension FASEB J 21 1689 1698 fj.06-7175com [pii] 10.1096/fj.06-7175com 1:CAS:528:DC%2BD2sXmsVWlu7o%3D 17289925 10.1096/fj.06-7175com (Pubitemid 46855614)
39. TA Morinelli JG Webb AA Jaffa PJ Privitera HS Margolius 2001 A metabolic fragment of bradykinin, Arg-Pro-Pro-Gly-Phe, protects against the deleterious effects of lipopolysaccharide in rats J Pharmacol Exp Ther 296 71 76 1:CAS:528:DC%2BD3MXosVWr 11123364
40. LG Fischer MW Hollmann DJ Horstman GF Rich 2000 Cyclooxygenase inhibitors attenuate bradykinin-induced vasoconstriction in septic isolated rat lungs Anesth Analg 90 625 631 10.1097/00000539-200003000-00023 1:CAS:528: DC%2BD3cXhvFWntLY%3D 10702448
41. LG Fischer JH Hilpert H Freise D Wendholt H Van Aken AW Sielenkamper 2004 Bradykinin-induced pulmonary vasoconstriction is time and inducible nitric oxide synthase dependent in a peritonitis sepsis model Anesth Analg 99 864 871 10.1213/01.ANE.0000133000.65613.F5 10.1213/01.ANE.0000133000.65613.F5 1:CAS:528:DC%2BD2cXmsl2gt74%3D 15333423 99/3/864 [pii] (Pubitemid 39100381)
42. K Matsumoto T Yamamoto R Kamata H Maeda 1984 Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease J Biochem 96 739 749 1:CAS:528:DyaL2cXlt1yhtr8%3D 6438075
43. J Potempa RN Pike 2009 Corruption of innate immunity by bacterial proteases J Innate Immun 1 70 87 10.1159/000181144 1:CAS:528: DC%2BD1MXhtFOmtLw%3D 19756242
44. ES Kalter WC van Dijk A Timmerman J Verhoef BN Bouma 1983 Activation of purified human plasma prekallikrein triggered by cell wall fractions of Escherichia coli and Staphylococcus aureus J Infect Dis 148 682 691 1:CAS:528:DyaL3sXmtFSlu7o%3D 6355312
45. H Herwald M Mörgelin A Olsén M Rhen B Dahlbäck W Müller-Esterl L Björck 1998 Activation of the contact-phase system on bacterial surfaces-a clue to serious complications in infectious diseases Nat Med 4 298 302 10.1038/nm0398-298 1:CAS:528:DyaK1cXhs1Kjsbo%3D 9500602 (Pubitemid 28144087)
46. T Yamada P Harber GW Pettit DA Wing CN Oster 1978 Activation of the kallikrein-kinin system in Rocky Mountain spotted fever Ann Intern Med 88 764 768 1:CAS:528:DyaE1cXkvVyhtr8%3D 307354 (Pubitemid 8351376)
47. M Rapala-Kozik J Karkowska A Jacher A Golda A Barbasz I Guevara-Lora A Kozik 2008 Kininogen adsorption to the cell surface of Candida spp International immunopharmacology 8 237 241 10.1016/j.intimp.2007.07.005 1:CAS:528: DC%2BD1cXisFygsA%3D%3D 18182233
48. E Andersson Nordahl V Rydengård M Mörgelin A Schmidtchen 2005 Domain 5 of high molecular weight kininogen is antibacterial J Biol Chem 280 34832 34839 10.1074/jbc.M507249200 (Pubitemid 41504617)
49. RC Araujo R Kettritz I Fichtner AC Paiva JB Pesquero M Bader 2001 Altered neutrophil homeostasis in kinin B1 receptor-deficient mice Biol Chem 382 91 95 10.1515/BC.2001.014 10.1515/BC.2001.014 1:CAS:528:DC%2BD3MXitFKjsrc%3D 11258678 (Pubitemid 32175618)
50. IM Frick P Akesson H Herwald M Mörgelin M Malmsten DK Nagler L Björck 2006 The contact system-a novel branch of innate immunity generating antibacterial peptides EMBO J 25 5569 5578 10.1038/sj.emboj.7601422 1:CAS:528:DC%2BD28Xht1Cnt7nN 17093496 (Pubitemid 44847197)
51. LM Leeb-Lundberg F Marceau W Müller-Esterl DJ Pettibone BL Zuraw 2005 International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences Pharmacol Rev 57 27 77 57/1/27 [pii] 10.1124/pr.57.1.2 1:CAS:528: DC%2BD2MXis1Gmtr0%3D 15734727 10.1124/pr.57.1.2 (Pubitemid 40283969)
52. E Schremmer-Danninger A Offner M Siebeck AA Roscher 1998 B1 bradykinin receptors and carboxypeptidase M are both upregulated in the aorta of pigs after LPS infusion Biochemical and biophysical research communications 243 246 252 S0006-291X(97)97999-7 [pii] 10.1006/bbrc.1997.7999 1:CAS:528: DyaK1cXpsVaisg%3D%3D 9473512 10.1006/bbrc.1997.7999 (Pubitemid 28414222)
53. SH Bengtson SB Phagoo A Norrby-Teglund L Påhlman M Mörgelin BL Zuraw LMF Leeb-Lundberg H Herwald 2006 Kinin receptor expression during Staphylococcus aureus infection Blood 108 2055 2063 10.1182/blood-2006-04-016444 1:CAS:528:DC%2BD28Xpsl2itrY%3D 16735595 (Pubitemid 44395021)
54. SH Bengtson C Sandén M Mörgelin PF Marx FLM Leeb-Lundberg JCM Meijers H Herwald 2009 Activation of TAFI on the surface of Streptococcus pyogenes evokes inflammatory reactions by modulating the kallikrein/kinin system J Innate Immun 1 18 28 10.1159/000145543 1:CAS:528:DC%2BD1MXjvV2lug%3D%3D
55. F Marceau D Regoli 2004 Bradykinin receptor ligands: therapeutic perspectives Nat Rev Drug Discov 3 845 852 10.1038/nrd1522 1:CAS:528: DC%2BD2cXotVSmtbg%3D 15459675 (Pubitemid 39405945)
56. AM Fein GR Bernard GJ Criner EC Fletcher JT Good Jr WA Knaus H Levy GM Matuschak HM Shanies RW Taylor TC Rodell 1997 Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and sepsis study group Jama 277 482 487 10.1001/jama.277.6. 482 1:CAS:528:DyaK2sXhsFChsbY%3D 9020273
57. VF Merino M Todiras LA Campos V Saul E Popova OC Baltatu JB Pesquero M Bader 2008 Increased susceptibility to endotoxic shock in transgenic rats with endothelial overexpression of kinin B(1) receptors J Mol Med 86 791 798 10.1007/s00109-008-0345-z 10.1007/s00109-008-0345-z 1:CAS:528: DC%2BD1cXnslGktbg%3D 18425495
58. JH Nuijens AJ Eerenberg-Belmer CC Huijbregts WO Schreuder RJ Felt-Bersma JJ Abbink LG Thijs CE Hack 1989 Proteolytic inactivation of plasma C1- inhibitor in sepsis The Journal of clinical investigation 84 443 450 10.1172/JCI114185 1:STN:280:DyaL1MzktVylsw%3D%3D 2668333
59. C Caliezi WA Wuillemin S Zeerleder M Redondo B Eisele CE Hack 2000 C1-esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema Pharmacol Rev 52 91 112 1:CAS:528:DC%2BD3cXjvVWgtb0%3D 10699156
60. C Caliezi S Zeerleder M Redondo B Regli HU Rothen R Zurcher-Zenklusen R Rieben J Devay CE Hack B Lammle WA Wuillemin 2002 C1-inhibitor in patients with severe sepsis and septic shock: beneficial effect on renal dysfunction Crit Care Med 30 1722 1728 10.1097/00003246-200208000-00008 1:CAS:528: DC%2BD38XmvFSnsrc%3D 12163783
61. CE Hack AC Ogilvie B Eisele AJ Eerenberg J Wagstaff LG Thijs 1993 C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2 Intensive Care Med 19 S19 28 10.1007/BF01738946 8053997
62. S Oehmcke O Shannon M von Köckritz-Blickwede M Mörgelin A Linder AI Olin L Björck H Herwald 2009 Treatment of invasive streptococcal infection with a peptide derived from human high-molecular weight kininogen Blood 114 444 451 blood-2008-10-182527 [pii] 10.1182/blood-2008-10-182527 1:CAS:528:DC%2BD1MXovVKls7w%3D 19433860 10.1182/blood-2008-10-182527
63. GR Bernard JL Vincent PF Laterre SP LaRosa JF Dhainaut A Lopez-Rodriguez JS Steingrub GE Garber JD Helterbrand EW Ely CJ Fisher Jr 2001 Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 699 709 10.1056/NEJM200103083441001 1:CAS:528:DC%2BD3MXitFamt7s%3D 11236773 (Pubitemid 32204987)